Cafepharma Today

Memorial Day Weekend 2025
We wish all our US visitors a safe and enjoyable holiday weekend. We remember those who have given their lives to defend and protect our country.

CP Today will resume on Tuesday, May 27

*please scroll down for all the latest news *

Make it like cafepharma, but for different industries. Learn more about CompanyUnderground

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

Current News

submit a press release

Merck KGaA sells women's health business to Teva for €285 million news
domain-b
Saturday, October 30, 2010 - 1:11pm
tags:
Merck KGaA, Teva Pharmaceuticals, Theramex
Lotus Pharma receives Chinese approval to initiate phase-I trials of asthma drug R-bambuterol
PharmaBiz
Saturday, October 30, 2010 - 1:09pm
tags:
Lotus, R-bambuterol hydrochloride, asthma
Pfizer ranks at the top in philanthropy
The Day
Saturday, October 30, 2010 - 1:07pm
tags:
Pfizer
Dr Reddys Labs a market performer: Karvy Stock Broking
MoneyControl
Saturday, October 30, 2010 - 1:06pm
tags:
Dr Reddy's
Taro Pharmaceutical net zooms by 93% in Q3
PharmaBiz
Saturday, October 30, 2010 - 1:05pm
tags:
Taro, earnings
AstraZeneca sues Watson Pharma over generic Crestor
PharmaBiz
Saturday, October 30, 2010 - 1:04pm
tags:
AstraZeneca, Watson Pharmaceuticals, Crestor
Evotec and APEIRON Biologics Build Pain Alliance
Benzinga
Saturday, October 30, 2010 - 1:02pm
tags:
Evotec, Apeiron, pain management, Downstream Regulatory Element Antagonistic Modulator
Novartis drug Afinitor® approved by FDA as first medication for children and adults with a benign brain tumor associated with tuberous sclerosis
PharmPro
Saturday, October 30, 2010 - 1:00pm
tags:
Novartis, Afinitor, tuberous sclerosis, brain tumors
7 Pharma Stocks Near 52-Week Highs
Motley Fool
Saturday, October 30, 2010 - 12:43pm
tags:
JNJ, Novartis, Merck, Abbott Laboratories, AstraZeneca, Novo Nordisk
Vertex, Merck Drugs Help More with Faster Cure for Hepatitis C in Studies
Bloomberg
Saturday, October 30, 2010 - 12:41pm
tags:
Vertex Pharmaceuticals, Merck, hepatitis C, Telaprevir, Roche, Pegasys
Merck's Investigational Medicine Boceprevir Achieved Significantly Higher SVR Rates In Treatment-Failure and Treatment-Naïve Adult Patients with Chronic Hepatitis C Genotype 1 Compared to Control
Yahoo/BusinessWire
Saturday, October 30, 2010 - 12:39pm
tags:
Merck, hepatitis C, Boceprevir
Cost Cuts Help Merck to Avert Revenue Losses
NY Times
Saturday, October 30, 2010 - 12:37pm
tags:
Merck, Vioxx
Merck Books $950 Million Vioxx Charge .
WSJ
Saturday, October 30, 2010 - 12:36pm
tags:
Merck, legal, Vioxx
Earnings Preview: Pfizer to tout new drugs, deals
Yahoo/AP
Saturday, October 30, 2010 - 12:35pm
tags:
Pfizer, earnings, tasocitinib, pain management, stroke, Laboratorio Teuto Brasileiro S.A
Pfizer Sues Apotex, Mylan to Block Generic Viagra
Bloomberg
Saturday, October 30, 2010 - 12:31pm
tags:
Pfizer, Apotex, Mylan, Viagra
Glaxo recalls 1 lot of Emo-Cort lotion in Canada
Yahoo/AP
Saturday, October 30, 2010 - 12:30pm
tags:
GSK, Emo-Cort, eczema, dermatitis
J&J probes Crucell's manufacturing mishap
Yahoo/AP
Saturday, October 30, 2010 - 12:28pm
tags:
JNJ, Crucell
Is Provenge The Most Important Medicine In Biotech?
Forbes
Saturday, October 30, 2010 - 12:27pm
tags:
Provenge, Dendreon, prostate cancer
Idera Pharmaceuticals Presents Phase 1 Data on IMO-2125 Demonstrating Induction of Broad Antiviral Immune Response in Null-Responder HCV Patients
Yahoo/BusinessWire
Saturday, October 30, 2010 - 12:23pm
tags:
Idera Pharmaceuticals, IMO-2125, hepatitis C
Viread® for Hepatitis B Maintains Antiviral Suppression with No Development of Resistance Through Four Years of Treatment
Yahoo/BusinessWire
Saturday, October 30, 2010 - 12:22pm
tags:
Viread, Gilead Sciences, hepatitis B

Pages

Latest CP Wire Articles

Hermes Intelligence Launches to Redefine Pharma Data Solutions [sponsored]
The Evolution of Medical Sales: What’s Changing in 2025?
FDA Scraps Key Vaccine Meetings—What It Means for Manufacturers
FDA approves Danziten, the first nilotinib treatment for Ph+ CML with no mealtime restrictions
Daily U.S. Flu Cases Expected to Nearly Double from Last Year by Late November, Predicts Novel Mathematical Forecasting Tool
PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition
Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research
First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study
Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth
Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies

Latest Pharmagather Articles

Inside a Scientific Paper Mill
In the Pipeline
Autoimmune Disease, Transformed?
In the Pipeline
Lose Your Crystalline Form and Go Amorphous
In the Pipeline
Alzheimer's Update: Infectious Agents and Gamma-Secretase Too
In the Pipeline
Obesity Without Metabolic Dysfunction?
In the Pipeline
New Cell Therapy For Resistant Hodgkins Patients
In the Pipeline
Escape From the Lysosome
In the Pipeline
Heavy Water in Your NMR Experiments, And Elsewhere
In the Pipeline
GIPR: Agonists and Antagonists Do the Same Thing, But How
In the Pipeline

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.